Language
EN
Leadgene Leadgene
Anti-EGFR Antibody [Clone C225] (Cetuximab Biosimilar)
Catalog Number

LDG0095YA

More Documents
Loading package & price...
  • Overview

    Description

    Cetuximab biosimilar is a recombinant monoclonal antibody which binds specifically to the human epidermal growth factor receptor (EGFR). Cetuximab biosimilar interacts with the extracellular region of EGFR to block ligand stimulation and has potent antitumor efficacy. This product is for research use only.

    Product Note

    Recommended dilution factor:
    ELISA:
    FACS:
    ICH:
    IFA:

    Note: Working dilution for specific application should be determined by the investigator to obtain the best conditions.

  • Specifications
    • Clonality

      Recombinant Human IgG

      Isotype

      IgG1

    • Clone Name

      clone C225

      Reactivity

      Human

    • Application

      ELISA, FACS, IHC, IFA

      Conjugation

      Unconjugated

    • Concentration

      1 mg/mL

      Buffer

      Azide free-phosphate buffered saline, 0.2 μm filter sterilized.

    • Specificity

      EGFR

      Form

      Liquid

  • Instruction
    • Shipping

      The product is shipped with polar packs. Upon receipt, store it immediately at -20°C or lower for long term storage.

      Stability & Storage

      This product is stable after storage at:

      • 2-8°C for 2 weeks under sterile conditions from date of receipt.
      • -20°C or -80°C for 12 months under sterile conditions from date of receipt.

      Avoid repeated freeze/thaw cycles.
      Suggestion: Divide antibody into several vials. Keep only vials for usage at 2-8°C.

  • Review

    Help others learn more about this product. Use the link below to share your experience.

  • Publication

    There are currently no publications. Use the link below to let us know.

  • Datasheet & Documents
    MSDS
    Manual
    1
    /
    1

Disclaimer:For Research Use or Further Manufacturing Only.

This site uses cookies as described in our Privacy Policy in order to improve your user experience and deliver customized advertising to you. Click “I Agree” to consent and continue.